Supreme Court sides with Monsanto in Roundup warning-label preemption case

The Supreme Court gave Bayer a major legal victory on Thursday, ruling 7-2 for Monsanto in a Roundup warning-label case and saying federal pesticide law can block state claims that would require a cancer warning the EPA has not demanded.

The decision is expected to affect thousands of existing and future Roundup lawsuits. It also strengthens Bayer's effort to contain litigation tied to the weedkiller since it acquired Monsanto in 2018.

The case, Monsanto v. Durnell, centered on whether the Federal Insecticide, Fungicide, and Rodenticide Act, known as FIFRA, preempts state failure-to-warn claims when the product's federally approved label does not include a cancer warning.

The court said those state-law claims are preempted in that situation. The ruling does not decide whether Roundup causes cancer. It addresses whether state law can force a warning on a label that federal regulators have already approved.

From Missouri to the Supreme Court

The dispute reached the justices after a Missouri jury awarded John Durnell $1.25 million in October 2023. His case became one of the many Roundup suits that have tested whether juries can impose warning obligations beyond the federal label.

Bayer has spent years trying to reduce the legal and financial exposure from that litigation. The company has already set aside billions of dollars for Roundup-related settlements and, according to earlier AP reporting, proposed a new $7.25 billion settlement package in February 2026.

Thursday's ruling changes that backdrop by weakening one of the most important legal theories plaintiffs have used in state courts. Bayer now has a stronger argument that EPA-approved labeling should control over different warning demands under state law.

The company and its supporters have long argued that pesticide labeling should not be governed by a patchwork of state verdicts when the federal regulator has approved the label. The court's decision gives that view its strongest backing yet.

What the court said

Justice Brett Kavanaugh wrote the majority opinion. Justice Ketanji Brown Jackson dissented, joined by Justice Neil Gorsuch.

The ruling turns on preemption, a legal doctrine that can block state law when it conflicts with federal requirements. In this case, the justices agreed that state claims demanding a cancer warning cannot stand where the EPA has not required one on the approved label.

That makes the opinion significant for more than just Roundup. It could shape how courts treat other pesticide and chemical warning cases that depend on state-law arguments against a federally approved label.

Reporters said Bayer and Monsanto welcomed the decision as a win for science, regulatory consistency and legal clarity. That response underscores how central the case is to the company's broader litigation strategy.

The ruling is narrower than the headlines may suggest in one important respect: it does not resolve the scientific fight over glyphosate and cancer. Instead, it answers who controls the warning language on the label.

What the ruling changes

The immediate effect is on the long-running Roundup docket. Plaintiffs who rely on state failure-to-warn theories now face a more difficult path in cases where the EPA has not required the warning they seek.

That could matter in both pending cases and future filings. Lower courts will now have to decide how broadly to apply the holding as they sort through Roundup litigation still moving through the system.

The decision also changes settlement leverage. Bayer can argue that a major category of warning-label claims has been cut back, while plaintiffs' lawyers will have to reassess what theories remain viable.

The company has already been under intense pressure from years of verdicts and settlement talks. A ruling from the Supreme Court in its favor gives Bayer room to argue that its legal exposure is not as open-ended as plaintiffs have claimed.

Why it matters beyond Roundup

The stakes reach beyond one product. The case sits inside a wider fight over whether federal pesticide labeling standards can block state consumer-protection claims.

If the federal label controls in cases like this, that logic could spill over to other defendants facing similar warning claims over pesticides and chemicals. That is why industry observers are watching the decision closely.

The EPA's role is central to that broader fight. The court's ruling reinforces the idea that, at least in this setting, federal labeling approval can limit what state courts may require.

Still unresolved is the underlying cause-of-action landscape. Plaintiffs may continue to pursue theories that do not depend on forcing a different warning label, but the ruling removes a major route they have used in state court.

What's next

Lower courts will now begin applying the decision to pending Roundup cases. One open question is which other theories of liability remain alive after the ruling and which will be dismissed or narrowed.

Another is the exact language in the majority opinion that will guide follow-on cases. That wording will matter as judges decide whether the decision reaches only warning-label claims or has broader practical effects.

The ruling could also affect settlement talks. Bayer may try to use it to push for better terms, while plaintiffs' lawyers will likely test what survives after the Supreme Court's preemption holding.

For now, the biggest immediate consequence is clear: Bayer has won a major round in one of the company's longest-running legal battles, and the Supreme Court has said EPA-approved pesticide labels can preempt state claims that seek different warning language.